Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John D Quisel. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John D Quisel har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:IRON / Disc Medicine, Inc. | Chief Executive Officer, Director | 226 064 |
| US:XLRN / Acceleron Pharma Inc | EVP, Chief Business Officer | 53 316 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John D Quisel. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John D Quisel som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | −13 264 | 226 064 | −5,54 | 62,86 | −833 775 | 14 210 383 | |
| 2026-02-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
A - Award | 55 200 | 239 328 | 29,98 | ||||
| 2025-12-19 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 12 300 | 184 128 | 7,16 | 1,01 | 12 423 | 185 969 | |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −16 888 | 171 828 | −8,95 | 93,65 | −1 581 549 | 16 091 572 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −16 356 | 188 716 | −7,98 | 92,96 | −1 520 398 | 17 542 398 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −4 337 | 205 072 | −2,07 | 92,21 | −399 920 | 18 909 935 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −2 419 | 209 409 | −1,14 | 90,97 | −220 064 | 19 050 565 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 40 000 | 211 828 | 23,28 | 9,86 | 394 400 | 2 088 624 |
| 2025-09-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 10 000 | 171 828 | 6,18 | 1,01 | 10 100 | 173 546 | |
| 2025-07-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −3 593 | 161 828 | −2,17 | 56,20 | −201 925 | 9 094 653 |
| 2025-07-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −31 207 | 165 421 | −15,87 | 55,23 | −1 723 600 | 9 136 400 |
| 2025-07-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 34 800 | 196 628 | 21,50 | 9,86 | 343 128 | 1 938 752 |
| 2025-07-08 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −5 200 | 161 828 | −3,11 | 55,09 | −286 454 | 8 914 684 |
| 2025-07-08 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 5 200 | 167 028 | 3,21 | 9,86 | 51 272 | 1 646 896 |
| 2025-04-08 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 7 000 | 161 828 | 4,52 | 1,01 | 7 070 | 163 446 | |
| 2025-02-20 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | −5 574 | 154 828 | −3,48 | 54,58 | −304 229 | 8 450 512 | |
| 2025-02-12 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
A - Award | 78 337 | 160 402 | 95,46 | ||||
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 10 000 | 82 065 | 13,88 | 1,01 | 10 100 | 82 886 | |
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −1 900 | 72 065 | −2,57 | 62,41 | −118 580 | 4 497 627 |
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −11 112 | 73 965 | −13,06 | 61,87 | −687 477 | 4 576 067 |
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 13 012 | 85 077 | 18,06 | 9,86 | 128 298 | 838 859 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −4 212 | 72 065 | −5,52 | 63,80 | −268 733 | 4 597 870 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −12 194 | 76 277 | −13,78 | 63,12 | −769 667 | 4 814 490 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −3 414 | 88 471 | −3,72 | 62,38 | −212 957 | 5 518 617 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 19 820 | 91 885 | 27,50 | 2,65 | 52 523 | 243 495 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −500 | 72 065 | −0,69 | 67,20 | −33 599 | 4 842 624 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −6 305 | 72 565 | −7,99 | 66,35 | −418 361 | 4 814 971 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −5 767 | 78 870 | −6,81 | 65,58 | −378 194 | 5 172 208 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | −219 | 84 637 | −0,26 | 64,66 | −14 160 | 5 472 510 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 12 791 | 84 856 | 17,75 | 1,01 | 12 919 | 85 705 |
| 2024-07-10 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 3 000 | 72 065 | 4,34 | 1,01 | 3 030 | 72 786 | |
| 2024-03-01 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
A - Award | 66 365 | 69 065 | 2 457,96 | ||||
| 2024-01-03 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 2 700 | 2 700 | 1,01 | 2 727 | 2 727 | ||
| 2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 242 | 53 316 | −7,37 | 52,52 | −222 790 | 2 800 156 |
| 2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 57 558 | −2,70 | 52,51 | −84 016 | 3 022 371 |
| 2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 584 | 59 158 | −5,71 | 45,23 | −162 104 | 2 675 716 |
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −1 562 | 0 | −100,00 | ||||
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −2 346 | 0 | −100,00 | ||||
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 0 | −100,00 | ||||
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 1 562 | 62 742 | 2,55 | 7,12 | 11 121 | 446 723 | |
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 2 346 | 61 180 | 3,99 | 5,28 | 12 387 | 323 030 | |
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 58 834 | 9,29 | 3,88 | 19 400 | 228 276 | |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −70 | 53 834 | −0,13 | 44,24 | −3 097 | 2 381 616 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 53 904 | −0,19 | 45,46 | −4 546 | 2 450 476 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 452 | 54 004 | −6,01 | 44,62 | −154 028 | 2 409 658 |
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 500 | 28 500 | |||||
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 800 | 57 456 | 9,12 | ||||
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −475 | 52 656 | −0,89 | 43,92 | −20 862 | 2 312 652 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 558 | 53 131 | −4,59 | 43,10 | −110 250 | 2 289 946 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 55 689 | −2,28 | 42,31 | −55 003 | 2 356 202 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 56 989 | −0,52 | 43,26 | −12 978 | 2 465 344 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 309 | 57 289 | −2,23 | 42,32 | −55 397 | 2 424 470 |
| 2018-05-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
| 2018-05-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 2 000 | 58 598 | 3,53 | ||||
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 56 598 | −0,18 | 39,16 | −3 916 | 2 216 378 |
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 104 | 56 698 | −1,91 | 38,33 | −42 316 | 2 173 234 |
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 950 | 28 950 | |||||
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 825 | 57 802 | 9,11 | ||||
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 333 | 52 977 | −7,56 | 42,42 | −183 806 | 2 247 284 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −8 | 57 310 | −0,01 | 38,03 | −304 | 2 179 499 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 57 318 | −1,04 | 39,37 | −23 622 | 2 256 610 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 505 | 57 918 | −7,22 | 38,29 | −172 496 | 2 217 680 |
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 46 300 | 46 300 | |||||
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 7 900 | 62 423 | 14,49 | ||||
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 400 | 54 523 | −2,50 | 27,56 | −38 584 | 1 502 654 |
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 55 923 | −0,53 | 26,43 | −7 929 | 1 478 045 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −11 500 | 5 000 | −69,70 | |||
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −13 671 | 15 329 | −47,14 | |||
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −781 | 1 562 | −33,33 | |||
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −45 952 | 56 223 | −44,97 | 38,05 | −1 748 474 | 2 139 285 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 11 500 | 102 175 | 12,68 | 3,88 | 44 620 | 396 439 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 13 671 | 90 675 | 17,75 | 24,11 | 329 608 | 2 186 174 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 781 | 77 004 | 1,02 | 7,12 | 5 561 | 548 268 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 688 | 2 343 | −66,68 | |||
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 250 | 0 | −100,00 | |||
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 500 | 16 500 | −25,00 | |||
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −21 438 | 76 223 | −21,95 | 32,14 | −689 017 | 2 449 807 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 688 | 97 661 | 5,04 | 7,12 | 33 379 | 695 346 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 250 | 92 973 | 7,21 | 5,28 | 33 000 | 490 897 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 86 723 | 6,77 | 3,88 | 21 340 | 336 485 |
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 800 | 30 800 | |||||
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 100 | 81 223 | 6,70 | ||||
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 500 | 22 000 | −20,00 | |||
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 400 | 76 123 | −1,81 | 34,17 | −47 838 | 2 601 123 |
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 100 | 77 523 | −5,02 | 33,07 | −135 587 | 2 563 686 |
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 81 623 | 7,23 | 3,88 | 21 340 | 316 697 |
| 2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 40 000 | 76 123 | 110,73 | ||||
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 039 | 27 500 | −3,64 | |||
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 461 | 0 | −100,00 | |||
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 200 | 36 123 | −5,74 | 31,74 | −69 828 | 1 146 544 |
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 300 | 38 323 | −7,93 | 30,22 | −99 726 | 1 158 121 |
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 039 | 41 623 | 2,56 | 3,88 | 4 031 | 161 497 |
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 461 | 40 584 | 12,35 | 5,88 | 26 231 | 238 634 |
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 895 | 6 250 | −48,54 | ||||
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −7 527 | 2 346 | −76,24 | ||||
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 895 | 36 123 | 19,50 | 5,28 | 31 126 | 190 729 | |
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 527 | 30 228 | 33,16 | 5,28 | 39 743 | 159 604 | |
| 2015-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 500 | 4 461 | −55,22 | |||
| 2015-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 500 | 22 701 | −19,50 | 30,00 | −165 000 | 681 030 |
| 2015-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 28 201 | 24,23 | 5,88 | 32 340 | 165 822 |
| 2015-06-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −7 701 | 28 539 | −21,25 | ||||
| 2015-06-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 701 | 22 701 | 51,34 | 3,88 | 29 880 | 88 080 | |
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 500 | 9 961 | −35,57 | |||
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 500 | 15 000 | −26,83 | 31,13 | −171 215 | 466 950 |
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 20 500 | 36,67 | 5,88 | 32 340 | 120 540 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 500 | 15 461 | −26,24 | |||
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 900 | 15 000 | −20,63 | 31,81 | −124 059 | 477 150 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 18 900 | −7,80 | 31,06 | −49 696 | 587 034 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 20 500 | 36,67 | 5,88 | 32 340 | 120 540 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 039 | 20 961 | −16,16 | |||
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 461 | 0 | −100,00 | |||
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −220 | 15 000 | −1,45 | 41,20 | −9 064 | 618 000 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 280 | 15 220 | −25,76 | 40,67 | −214 738 | 618 997 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 039 | 20 500 | 24,54 | 5,88 | 23 749 | 120 540 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 461 | 16 461 | 9,74 | 5,88 | 8 591 | 96 791 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 0 | −100,00 | |||
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 15 000 | −5,06 | 42,05 | −33 640 | 630 750 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 200 | 15 800 | −16,84 | 41,28 | −132 096 | 652 224 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 19 000 | 26,67 | 5,08 | 20 320 | 96 520 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 500 | 1 461 | −79,01 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 4 000 | −33,33 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 4 000 | −33,33 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −101 | 15 000 | −0,67 | 42,06 | −4 248 | 630 900 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 066 | 15 101 | −6,59 | 41,77 | −44 527 | 630 769 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 333 | 16 167 | −21,14 | 40,34 | −174 793 | 652 177 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 20 500 | 36,67 | 5,88 | 32 340 | 120 540 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 | 15 000 | −0,01 | 42,07 | −42 | 631 050 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 15 001 | −7,97 | 41,50 | −53 950 | 622 542 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 699 | 16 301 | −14,21 | 40,65 | −109 714 | 662 636 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 19 000 | 11,76 | 5,08 | 10 160 | 96 520 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 17 000 | 13,33 | 1,80 | 3 600 | 30 600 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 438 | 6 961 | −25,94 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 500 | 6 000 | −20,00 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 562 | 12 145 | −11,40 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −500 | 2 000 | −20,00 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 0 | −100,00 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 500 | 15 000 | −26,83 | 40,12 | −220 660 | 601 800 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 438 | 20 500 | 13,50 | 5,88 | 14 335 | 120 540 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 18 062 | 9,06 | 5,08 | 7 620 | 91 755 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 562 | 16 562 | 10,41 | 5,28 | 8 247 | 87 447 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 15 000 | −3,23 | 40,62 | −20 310 | 609 300 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 500 | 15 500 | −18,42 | 39,85 | −139 475 | 617 675 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 500 | 19 000 | 2,70 | 1,80 | 900 | 34 200 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 500 | 18 500 | 23,33 | 0,92 | 3 220 | 17 020 |
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −15 000 | 36 240 | −29,27 | ||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 15 000 | 15 000 | 3,88 | 58 200 | 58 200 | ||
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 3 500 | −53,33 | |||
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 41,72 | −104 300 | |
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 2 500 | −37,50 | 40,72 | −61 080 | 101 800 |
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 4 000 | 0,92 | 3 680 | 3 680 | |
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 7 500 | −34,78 | |||
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −675 | 0 | −100,00 | 34,72 | −23 436 | |
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 325 | 675 | −83,12 | 33,24 | −110 523 | 22 437 |
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 4 000 | 0,92 | 3 680 | 3 680 | |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 899 | 7 031 | −21,27 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 101 | 9 399 | −24,81 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 043 | 0 | −100,00 | 33,60 | −102 245 | |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 957 | 3 043 | −39,14 | 32,42 | −63 446 | 98 654 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 899 | 5 000 | 61,24 | 7,12 | 13 521 | 35 600 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 101 | 3 101 | 5,88 | 18 234 | 18 234 | |
| 2014-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 11 500 | −25,81 | |||
| 2014-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 000 | 0 | −100,00 | 29,02 | −116 080 | |
| 2014-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 4 000 | 0,92 | 3 680 | 3 680 | |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 570 | 8 930 | −28,56 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 430 | 13 707 | −20,02 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 000 | 0 | −100,00 | 30,01 | −210 070 | |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 570 | 7 000 | 104,08 | 7,12 | 25 418 | 49 840 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 430 | 3 430 | 5,28 | 18 110 | 18 110 | |
| 2014-09-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 15 500 | −11,43 | |||
| 2014-09-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 25,43 | −50 860 | |
| 2014-09-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 863 | 17 137 | −31,45 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 137 | 9 873 | −24,11 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 17 500 | −10,26 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −11 000 | 0 | −100,00 | 30,02 | −330 220 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 863 | 11 000 | 250,65 | 5,28 | 41 517 | 58 080 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 137 | 3 137 | 5,28 | 16 563 | 16 563 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 29,79 | −59 580 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 000 | 13 010 | −18,74 | |||
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 19 500 | −9,30 | |||
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 000 | 0 | −100,00 | 30,12 | −90 360 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 5,28 | 15 840 | 15 840 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −900 | 0 | −100,00 | 29,71 | −26 739 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 900 | −55,00 | 28,70 | −31 570 | 25 830 |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −2 740 | 16 010 | −14,61 | |||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −4 260 | 51 240 | −7,68 | |||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −2 000 | 21 500 | −8,51 | |||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 700 | 0 | −100,00 | 34,13 | −92 151 | |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 300 | 2 700 | −70,00 | 33,86 | −213 318 | 91 422 |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 740 | 9 000 | 43,77 | 5,28 | 14 467 | 47 520 |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 260 | 6 260 | 213,00 | 3,88 | 16 529 | 24 289 |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 000 | 55 500 | −11,20 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 23 500 | −7,84 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −900 | 0 | −100,00 | 32,20 | −28 980 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 100 | 900 | −87,14 | 31,29 | −190 869 | 28 161 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 31,49 | −62 980 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 25 500 | −7,27 | |||
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 36,13 | −18 065 | |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 500 | −75,00 | 35,75 | −53 625 | 17 875 |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 |